SCHEMBL6629403

SCHEMBL6629403

Cc1ccccc1NC(=O)c1cc2cc(C(=O)O)ccc2cc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.61
RAB9A P51151 3/20 0.61
POLB P06746 8/20 0.57
KDM4E B2RXH2 3/20 0.57
MAPT P10636 3/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
NPY1R P25929 1/20 0.57
NPY2R P49146 1/20 0.57
HPGD P15428 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HSD17B10 Q99714 2/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
MCL1 Q07820 1/20 0.52
AKR1C3 P42330 1/20 0.50
PPARG P37231 1/20 0.50
MAOB P27338 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6577646 0.92 NPC1 (0.72) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL29771385 0.87 POLB (0.69) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL5681508 0.87 POLB (0.69) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL30516994 0.87 POLB (0.72) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL29372498 0.87 POLB (0.72) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL1344307 0.87 POLB (0.72) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL7084829 0.84 HSD17B10 (0.67) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL11237313 0.84 POLB (0.72) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL3925183 0.83 PLG (0.62) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL11242411 0.82 NPC1 (0.65) NPC1RAB9APOLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1283205-B1 NAPHTHOL DERIVATIVES UENO SEIYAKU OYO KENKYUJO KK (JP) 2004-09-22 EP disclosed
EP-1283205-A1 NAPHTHOL DERIVATIVES KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2003-02-12 EP disclosed
US-20020151720-A1 NAPHTHOL DERIVATIVES KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2002-10-17 US disclosed
US-6451988-B1 AN AZO COMPOUND AND A METAL COMPLEX WHICH ARE SYNTHESIZED WITH THE NAPHTHOL DERIVATIVE KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2002-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151720-A1 NAPHTHOL DERIVATIVES NAP1L1, IK, NAP1L4 NPC1 1203/4885RAB9A 3387/4885POLB 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.